These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 755052)

  • 1. Nonsuppressible insulin-like activity (NSILA). I. Development of a new sensitive competitive protein-binding assay for determination of serum levels.
    Schalch DS; Heinrich UE; Koch JG; Johnson CJ; Schlueter RJ
    J Clin Endocrinol Metab; 1978 Apr; 46(4):664-71. PubMed ID: 755052
    [No Abstract]   [Full Text] [Related]  

  • 2. Lack of a simple relationship between endogenous growth hormone and NSILA-s related peptides.
    Megyesi K; Gorden P; Kahn R
    J Clin Endocrinol Metab; 1977 Aug; 45(2):330-8. PubMed ID: 885996
    [No Abstract]   [Full Text] [Related]  

  • 3. Nonsuppressible insulin-like activity (NSILA). II. Regulation of serum concentrations by growth hormone and insulin.
    Heinrich UE; Schalch DS; Koch JG; Johnson CJ
    J Clin Endocrinol Metab; 1978 Apr; 46(4):672-8. PubMed ID: 573281
    [No Abstract]   [Full Text] [Related]  

  • 4. Demonstration of a specific serum carrier protein of nonsuppressible insulin-like activity in vivo.
    Kaufmann U; Zapf J; Torretti B; Froesch ER
    J Clin Endocrinol Metab; 1977 Jan; 44(1):160-6. PubMed ID: 833254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in NSILA-S in response to somatotropin administration and hypophysectomy.
    Franklin RC; Rennie GC; Burger HG; Cameron DP
    J Clin Endocrinol Metab; 1978 Jul; 47(1):91-6. PubMed ID: 263296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of the liver in regulating somatomedin activity: hormonal effects on the synthesis and release of insulin-like growth factor and its carrier protein by the isolated perfused rat liver.
    Schalch DS; Heinrich UE; Draznin B; Johnson CJ; Miller LL
    Endocrinology; 1979 Apr; 104(4):1143-51. PubMed ID: 436753
    [No Abstract]   [Full Text] [Related]  

  • 7. Inhibition of the action of nonsuppressible insulin-like activity on isolated rat fat cells by binding to its carrier protein.
    Zapf J; Schoenle E; Jagars G; Sand I; Grunwald J; Froesch ER
    J Clin Invest; 1979 May; 63(5):1077-84. PubMed ID: 447829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NSILA and foetal growth.
    Heinrich UE; Schalch DS; Jawadi MH; Johnson CJ
    Acta Endocrinol (Copenh); 1979 Mar; 90(3):534-43. PubMed ID: 425788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum levels of insulin-like growth factor (IGF) and its carrier protein in various metabolic disorders.
    Zapf J; Morell B; Walter H; Laron Z; Froesch ER
    Acta Endocrinol (Copenh); 1980 Dec; 95(4):505-17. PubMed ID: 7006291
    [No Abstract]   [Full Text] [Related]  

  • 10. Serum levels of the acid-ethanol soluble component of non-suppressible insulin-like activity in untreated and treated streptozotocin-diabetic rats.
    Franklin RC; Rennie GC; Cameron DP
    J Endocrinol; 1979 Jun; 81(3):331-7. PubMed ID: 469463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Receptor binding and effects of insulin and NSILA-S on glucose transport and metabolism in adipocytes from hypophysectomized rats.
    Schoenle E; Zapf J; Froesch ER
    Diabetologia; 1979 Jan; 16(1):41-6. PubMed ID: 761737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amino-terminal sequences of two polypeptides from human serum with nonsuppressible insulin-like and cell-growth-promoting activities: evidence for structural homology with insulin B chain.
    Rinderknecht E; Humbel RE
    Proc Natl Acad Sci U S A; 1976 Dec; 73(12):4379-81. PubMed ID: 1069990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of serum nonsuppressible insulin-like activity (NSILA) in wound healing. I. Influence of thyroparathyroidectomy on serum NSILA and wound healing in the rat.
    Poffenbarger PL; Haberal MA
    Surgery; 1976 Nov; 80(5):608-16. PubMed ID: 982280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A bioassay for NSILA-S in individual serum samples and its relationship to somatotropin.
    Franklin RC; Rennie GC; Burger HG; Cameron DP
    J Clin Endocrinol Metab; 1976 Nov; 43(5):1164-9. PubMed ID: 993319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of serum nonsuppressible insulin-like activity (NSILA) in compensatory renal growth.
    Poffenbarger PL; Prince MJ
    Growth; 1976 Mar; 40(1):83-97. PubMed ID: 177337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radioimmunoassay for non-suppressible insulin-like activity.
    Reber K; Liske R
    Horm Res; 1976; 7(4-5):201-13. PubMed ID: 1017791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for the existence in human serum of large molecular weight nonsuppressible insulin-like activity (NSILA) different from the small molecular weight forms.
    Zapf J; Jagars G; Sand I; Froesch ER
    FEBS Lett; 1978 Jun; 90(1):135-40. PubMed ID: 658429
    [No Abstract]   [Full Text] [Related]  

  • 18. Nonsuppressible insulinlike activity (NSILA) and the glucose dyshomeostasis of agonal sepsis.
    Viray RE; Filkins JP
    Adv Shock Res; 1983; 9():31-41. PubMed ID: 6349307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and high yield purification of insulin-like growth factors (nonsuppressible insulin-like activities and somatomedins) from human plasma by use of endogenous binding proteins.
    Ginsberg BH; Kahn CR; Roth J; Megyesi K; Baumann G
    J Clin Endocrinol Metab; 1979 Jan; 48(1):43-9. PubMed ID: 422704
    [No Abstract]   [Full Text] [Related]  

  • 20. Determination of nonsuppressible insulin-like activity in human serum by a sensitive protein-binding assay.
    Zapf J; Kaufmann U; Eigenmann EJ; Froesch ER
    Clin Chem; 1977; 23(4):677-82. PubMed ID: 844163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.